BeStock  
Stocks › Biotechnology › GERN

Geron GERN

US equityMarket cap rank #3434Biotechnology
$1.20 −$0.01 (-0.83%)
Pre-market · Oct 8, 8:20 am ET · After hours $1.20 0.00%
Open$1.21
Prev close$1.21
Day range$1.19 – $1.22
Volume5.14M
Market cap$770.97M
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$57.48M+17.2% YoY
Operating profit-$12.65M-1.6% YoY
Net profit-$16.68M-1.9% YoY
Diluted EPS-$0.02+0.0% YoY
Free cash flow-$16.05M+41.7% YoY
Operating cash flow-$15.83M

Revenue, last 8 quarters

$28.3MSep '24$47.5MDec '24$39.6MMar '25$49.0MJun '25$47.2MSep '25$48.0MDec '25$51.8MMar '26$57.5MJun '26

Net profit, last 8 quarters

$-26.4MSep '24$-25.4MDec '24$-19.8MMar '25$-16.4MJun '25$-18.4MSep '25$-28.9MDec '25$-3.6MMar '26$-16.7MJun '26

Diluted EPS by quarter

-0.04Sep '24-0.04Dec '24-0.03Mar '25-0.02Jun '25-0.03Sep '25-0.05Dec '25-0.01Mar '26-0.02Jun '26

Free cash flow by quarter

$-58.9MSep '24$-43.8MDec '24$-48.0MMar '25$-27.6MJun '25$-13.5MSep '25$-22.1MDec '25$-63.2MMar '26$-16.1MJun '26

Annual revenue

$253.0KFY20$1.4MFY21$596.0KFY22$237.0KFY23$77.0MFY24$183.9MFY25

Profitability & balance sheet

Gross margin93.5%
Operating margin-17.2%
Net margin-33.1%
Return on equity-28.3%
Return on assets-12.6%
Return on invested capital-14.4%
Current ratio6.92
Liabilities / assets57.9%
Cash & investments$300.85M
Total debt$121.13M
Net cash (debt)$179.72M

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Revenue as Reported $57.48M $51.84M – – $47.23M
Total Operating Revenue $57.48M $51.84M $183.88M $48.02M $47.23M
Cost of Revenue $9.24M $1.69M $4.75M $1.31M $1.04M
Gross Profit $48.24M $50.15M $179.14M $46.71M $46.18M
Operating Expense $60.89M $50.38M $230.69M $55.22M $60.07M
Selling and Admin Expenses $38.86M $35.43M $159.26M $41.67M $39.00M
Research & Development $22.03M $14.96M $71.43M $13.55M $21.07M
Operating Profit -$12.65M -$236,000.00 -$51.55M -$8.51M -$13.89M
Net Non-Operating Interest Income (Expense) -$4.18M -$3.73M -$14.54M -$3.25M -$4.38M
Non-Operating Interest Income $2.97M $3.42M $18.12M $4.05M $4.26M
Non-Operating Interest Expense $7.15M $7.15M $32.66M $7.30M $8.64M
Other Income (Expense) $148,000.00 $320,000.00 -$17.41M -$17.10M -$161,000.00
Special Income (Charges) $157,000.00 $394,000.00 -$17.03M – –
-Less:Restructuring and Mergern & Acquisition -$157,000.00 -$394,000.00 $17.03M – –
Other Non-Operating Income (Expenses) -$9,000.00 -$74,000.00 -$375,000.00 -$70,000.00 -$161,000.00
Pretax Profit -$16.68M -$3.64M -$83.50M -$28.86M -$18.43M
Net Profit -$16.68M -$3.64M -$83.50M -$28.86M -$18.43M
Profit from Continuing Operations -$16.68M -$3.64M -$83.50M -$28.86M -$18.43M
Net Income to Parent Company -$16.68M -$3.64M -$83.50M -$28.86M -$18.43M
Net Income to Common Stockholders -$16.68M -$3.64M -$83.50M -$28.86M -$18.43M
Basic EPS -$0.02 -$0.01 -$0.13 -$0.05 -$0.03
Diluted EPS -$0.02 -$0.01 -$0.13 -$0.05 -$0.03

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $519.01M $534.12M $570.54M $570.54M $567.38M
Total Current Assets $486.34M $498.53M $520.27M $520.27M $522.34M
Cash and Cash Equivalents & Short-Term Investments $300.85M $312.40M $357.92M $357.92M $380.53M
-Cash and Cash Equivalents $62.64M $68.90M $77.56M $77.56M $78.12M
-Short Term Investments $238.21M $243.51M $280.36M $280.36M $302.42M
Receivables $53.50M $44.10M $39.23M $39.23M $37.66M
-Accounts Receivable $51.64M $41.88M $36.99M $36.99M $35.36M
-Accrued Interest Receivable $1.86M $2.21M $2.24M $2.24M $2.30M
Inventory $123.60M $133.29M $116.64M $116.64M $95.42M
Restricted Cash $1.89M $1.88M $1.88M $1.88M $1.88M
Other Current Assets $6.50M $6.86M $4.61M $4.61M $6.86M
Total Non-Current Assets $32.67M $35.59M $50.27M $50.27M $45.04M
Net PPE $2.85M $2.96M $3.04M $3.04M $3.31M
-Gross PPE $2.85M $2.96M $5.24M $5.24M $3.31M
Investments and Advances $24.12M $26.69M $41.29M $41.29M $39.06M
-Available for Sale Securities $24.12M $26.69M – – $39.06M
Other Non-Current Assets $5.70M $5.94M $5.95M $5.95M $2.67M
Total Liabilities $300.40M $305.01M $344.67M $344.67M $318.68M
Total Current Liabilities $70.33M $73.57M $111.54M $111.54M $87.71M
Payables $8.81M $12.72M $11.26M $11.26M $11.11M
-Accounts Payable $8.81M $12.72M $11.26M $11.26M $11.11M
Current Accrued Expenses $24.01M $25.40M $47.85M $47.85M $39.93M
Short-Term Debt and Capital Lease Obligation $1.01M $1.01M $1.00M $1.00M $994,000.00
-Current Capital Lease Obligation $1.01M $1.01M $1.00M $1.00M $994,000.00
Current Deferred Liabilities $6.70M $5.56M $3.49M $3.49M –
Other Current Liabilities $20.69M $19.39M $17.45M $17.45M $19.29M
Total Non-Current Liabilities $230.06M $231.44M $233.13M $233.13M $230.96M
Long Term Debt and Capital Lease Obligation $121.13M $121.06M $120.99M $120.99M $120.92M
-Long Term Debt $120.13M $119.83M $119.55M $119.55M $119.26M
-Long Term Capital Lease Obligation $1.00M $1.23M $1.45M $1.45M $1.66M
Other Non-Current Liabilities $108.93M $110.38M $112.13M $112.13M $110.04M
Total Equity $218.61M $229.11M $225.87M $225.87M $248.71M
Stockholders' Equity $218.61M $229.11M $225.87M $225.87M $248.71M
Capital Stock $642,000.00 $641,000.00 $640,000.00 $640,000.00 $638,000.00
-Common Stock $642,000.00 $641,000.00 $640,000.00 $640,000.00 $638,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 –
Additional Paid-In Capital $2.09B $2.09B $2.08B $2.08B $2.07B
Retained Earnings -$1.88B -$1.86B -$1.86B -$1.86B -$1.83B
Gains/Losses Not Affecting Retained Earnings -$339,000.00 -$191,000.00 $269,000.00 $269,000.00 $408,000.00
-Accumulated Depreciation – – -$2.20M -$2.20M –
-Held to Maturity Securities – – $41.29M $41.29M –

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow -$15.83M -$62.91M -$111.04M -$22.07M -$13.58M
Net cash flow from continuing operations -$15.83M -$62.91M -$111.04M -$22.07M -$13.58M
Net Income from Continuing Operations -$16.68M -$3.64M -$83.50M -$28.86M -$18.43M
Depreciation & Depletion & Amortization $332,000.00 $326,000.00 $1.20M $275,000.00 $312,000.00
Other Non-Cash Items $150,000.00 $477,000.00 $20.02M $14.69M $1.64M
Change in Working Capital -$9.38M -$63.91M -$68.54M -$12.47M -$2.32M
-Change in Receivables -$8.94M -$4.89M -$377,000.00 -$966,000.00 $1.27M
-Change in Inventory $3.35M -$16.65M -$77.92M -$21.21M -$26.30M
-Change in Prepaid Assets $974,000.00 -$2.23M -$1.42M -$1.59M $1.34M
-Change in Payables and Accrued Expense -$4.17M -$18.91M $18.45M – –
-Change in Other Current Liabilities -$220,000.00 -$212,000.00 -$14.96M -$14.84M $274,000.00
-Change In Other Working Capital -$382,000.00 -$21.01M $7.69M – –
Net cash flow from investing $8.30M $51.86M $107.25M $21.15M $13.35M
Net Cash Flow from Continuing Investing Activities $8.30M $51.86M $107.25M $21.15M $13.35M
Net PPE Purchase and Sale -$223,000.00 -$252,000.00 -$49,000.00 $0.00 $89,000.00
Net Investment Purchase and Sale $8.52M $52.11M $107.30M $21.15M $13.26M
Financing Cash Flow $1.38M $2.43M $2.27M $378,000.00 $542,000.00
Net Cash Flow from Continuing Financing Activities $1.38M $2.43M $2.27M $378,000.00 $542,000.00
Proceeds from Stock Option Exercised $1.38M $2.43M $2.27M $378,000.00 $542,000.00
Ending Cash Balance $64.53M $70.78M $79.44M $79.44M $79.99M
Net Change in Cash -$6.15M -$8.63M -$1.52M -$544,000.00 $314,000.00
Beginning Cash Balance $70.78M $79.44M $80.88M $79.99M $79.60M
Effect of Exchange Rate Changes -$100,000.00 -$36,000.00 $87,000.00 -$9,000.00 $75,000.00
Free Cash Flow -$16.05M -$63.16M -$111.09M -$22.07M -$13.49M
Net Issuance Payments Of Debt – – $0.00 – –
Net Common Stock Issuance – – $0.00 $0.00 –

Discussion

No comments yet — be the first to weigh in on GERN.

Leave a comment

Scroll to Top